Ensign Peak Advisors, Inc Homology Medicines, Inc. Transaction History

Ensign Peak Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.39 - $3.12 $5,768 - $12,948	-4,150 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.64 - $7.78 $15,106 - $32,287	4,150 New	4,150 $15,000
Q4 2020 Feb 12, 2021	SELL	$8.92 - $13.29 $213,660 - $318,335	-23,953 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$9.94 - $16.59 $238,092 - $397,380	23,953 New	23,953 $256,000
Q1 2020 May 11, 2020	SELL	$12.5 - $22.04 $161,875 - $285,418	-12,950 Closed	0 $0

Q4 2019 Feb 14, 2020	BUY	$11.42 - $22.19 $147,889 - $287,360	12,950 New	12,950 $268,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.